Glycopyrronium Bromide inhaler

BNF:
3.1
Status:
Grey
Decision Date:
June 2015
 

Comments

GREY 2nd line LAMA:1,2

  • Seebri Breezhaler and caps (DPI) (Decision date - August 19)

Grey Drug Classifications

  • 1: Lack of data on effectiveness compared with standard therapy
  • 2: Lack of data on safety compared with standard therapy

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app